# Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

> **NCT05639946** · PHASE3 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 44 (actual)

## Conditions studied

- Spinal Cord Injuries
- Neuropathic Pain

## Interventions

- **DRUG:** brivaracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05639946
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-10-07
- **Final completion:** 2024-10-16
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05639946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05639946, "Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05639946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*